title: Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.
abstract: We reviewed 776 patients who were culture positive for Aspergillus species at the hospital from 2000 to 2009. The isolates were collected for species identification by oligonucleotide hybridization and sequence analysis. A total of 96 cases of proven or probable IA were identified according to published criteria. The incidence of IA has increased significantly during the study period. Aspergillus fumigatus and A. flavus (41.7% each) were equally prevalent causative species. IA due to unusual species including A. nidulans (n=2), A. versicolor (n=2), and A. tubingensis (n=1) were also found. Among patients with IA, 55.2% had hematological disorder, 19.8% had underlying lung disorder, and 10.4% had autoimmune disease. The isolates species (P<0.001) and underlying disease (P<0.001) significantly affect the association of a positive culture with invasive disease. The overall mortality at three months was 62.5%, which remained stable throughout the study period. Multivariate analysis identified prior steroid use (P=0.007) as a significant risk factor for death, while surgery (P=0.030) and voriconazole (P=0.012) had protective effects. In conclusion, autoimmune disorders and underlying pulmonary diseases should also be considered as important predisposing factors of IA. Further emphasis on surgery and voriconazole in the management of IA might be beneficial.
authors: School of Medicine, National Taiwan University College of Medicine, Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
authors: H-C
authors: HC
authors: Hsiue
authors: T-H
authors: TH
authors: Wu
authors: T-C
authors: TC
authors: Chang
authors: Y-C
authors: YC
authors: Hsiue
authors: Y-T
authors: YT
authors: Huang
authors: P-I
authors: PI
authors: Lee
authors: P-R
authors: PR
authors: Hsueh
mesh_terms: D000046:Academic Medical Centers; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000008:administration & dosage; D001230:Aspergillus / Q000145:classification* / Q000302:isolation & purification*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D015994:Incidence; D007223:Infant; D055744:Invasive Pulmonary Aspergillosis / Q000453:epidemiology* / Q000382:microbiology* / Q000401:mortality / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000008:administration & dosage; D012307:Risk Factors; D016019:Survival Analysis; D013624:Taiwan / Q000453:epidemiology; D014230:Triazoles / Q000008:administration & dosage; D065819:Voriconazole; D055815:Young Adult
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole